1,25-dihydroxyvitamin D3 impairs NF-κB activation in human naive B cells

被引:62
|
作者
Geldmeyer-Hilt, Kerstin [1 ]
Heine, Guido [1 ,2 ]
Hartmann, Bjoern [1 ]
Baumgrass, Ria [2 ]
Radbruch, Andreas [2 ]
Worm, Margitta [1 ]
机构
[1] Charite, Allergie Ctr Charite, CCM, Klin Dermatol & Allergol, D-10117 Berlin, Germany
[2] Deutsch Rheuma Forschungszentrum Berlin, D-10117 Berlin, Germany
关键词
Vitamin D; Calcitriol; Vitamin D receptor; NF-kappa B; Naive B cells; VITAMIN-D-RECEPTOR; DOWN-REGULATION; P50; SUBUNIT; GENE; LYMPHOCYTES; PROMOTER; SUBPOPULATIONS; RESPONSES; DEFECTS;
D O I
10.1016/j.bbrc.2011.03.078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1 alpha,25-dihydroxyvitamin D-3 (calcitriol), the bioactive metabolite of vitamin D, modulates the activation and inhibits IgE production of anti-CD40 and IL-4 stimulated human peripheral B cells. Engagement of CD40 results in NF-kappa B p50 activation, which is essential for the class switch to IgE. Herein, we investigated by which mechanism calcitriol modulates NF-kappa B mediated activation of human naive B cells. Naive B cells were predominantly targeted by calcitriol in comparison with memory B cells as shown by pronounced induction of the VDR target gene cyp24a1. Vitamin D receptor activation resulted in a strongly reduced p105/p50 protein and mRNA expression in human naive B cells. This effect is mediated by impaired nuclear translocation of p65 and consequently reduced binding of p65 to its binding site in the p105 promoter. Our data indicate that the vitamin D receptor reduces NF-kappa B activation by interference with NF-kappa B p65 and p105. Thus, the vitamin D receptor inhibits costimulatory signal transduction in naive B cells, namely by reducing CD40 signaling. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:699 / 702
页数:4
相关论文
共 50 条
  • [41] RECEPTORS FOR 1,25-DIHYDROXYVITAMIN D3 IN GYNECOLOGIC NEOPLASMS
    SAUNDERS, DE
    CHRISTENSEN, C
    LAWRENCE, WD
    MALVIYA, VK
    MALONE, JM
    WILLIAMS, JR
    DEPPE, G
    GYNECOLOGIC ONCOLOGY, 1992, 44 (02) : 131 - 136
  • [42] Synthesis of 1-alleyl-1,25-dihydroxyvitamin D3
    Ishida, Hiroki
    Shimizu, Masato
    Yamamoto, Keiko
    Iwasaki, Yukiko
    Yamada, Sachiko
    Yamaguchi, Kentaro
    Journal of Organic Chemistry, 1995, 60 (06):
  • [43] 1α-hydroxylase transcript is regulated by PTR but not by 1,25-dihydroxyvitamin D3 in AOK-B50 cells.
    Brenza, HL
    DeLuca, HF
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S214 - S214
  • [44] 1,25-dihydroxyvitamin D3 -: a hormone with immunomodulatory properties
    Lemire, J
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2000, 59 : 24 - 27
  • [45] TOXIC EFFECTS OF 1,25-DIHYDROXYVITAMIN D3 IN RATS
    HARTENBOWER, DL
    STANLEY, TM
    COBURN, JW
    NORMAN, AW
    KIDNEY INTERNATIONAL, 1976, 10 (06) : 490 - 490
  • [46] A-ring analogs of 1,25-dihydroxyvitamin D3
    Glebocka, Agnieszka
    Chiellini, Grazia
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2012, 523 (01) : 48 - 57
  • [47] 1,25-Dihydroxyvitamin D3 in the pathogenesis and treatment of osteoporosis
    H. F. Deluca
    Osteoporosis International, 1997, 7 : 24 - 29
  • [48] DEVELOPMENT AND APPLICATIONS OF A RADIOIMMUNOASSAY FOR 1,25-DIHYDROXYVITAMIN D3
    BOUILLON, R
    VANDEPITTE, P
    JOURNAL BELGE DE RADIOLOGIE, 1980, 63 (06): : 719 - 719
  • [49] The mechanism of 1,25-dihydroxyvitamin D3 autoregulation in keratinocytes
    Xie, ZJ
    Munson, SJ
    Huang, NW
    Portale, AA
    Miller, WL
    Bikle, DD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (40) : 36987 - 36990
  • [50] THE GENOMIC MECHANISM OF ACTION OF 1,25-DIHYDROXYVITAMIN D3
    OZONO, K
    SONE, T
    PIKE, JW
    JOURNAL OF BONE AND MINERAL RESEARCH, 1991, 6 (10) : 1021 - 1027